We are live on
!
Find out more
BG
Bellevue Group Portfolio holdings
AUM
$4.2B
1-Year Est. Return
54.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.16%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$5.86B
AUM Growth
+$4.04B
(+222%)
Cap. Flow
+$4.05B
Cap. Flow
% of AUM
69.18%
Top 10 Holdings %
Top 10 Hldgs %
42.44%
Holding
220
New
83
Increased
86
Reduced
22
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$541M |
| 2 |
Incyte
INCY
|
+$293M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$290M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$228M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$28.3M |
| 2 |
Cencora
COR
|
+$19.9M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$16.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$14.7M |
| 5 |
Illumina
ILMN
|
+$9.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.72% |
| 2 | Technology | 0.56% |
| 3 | Industrials | 0.42% |
| 4 | Financials | 0.06% |
| 5 | Consumer Discretionary | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Analog Devices
ADI
$185B
| $336K | 0.01% |
+2,973
| New | +$322K |
|
177
Colgate-Palmolive
CL
$72.1B
| $333K | 0.01% |
+4,651
| New | +$330K |
|
178
Trip.com Group
TCOM
$27.1B
| $333K | 0.01% |
+9,032
| New | +$356K |
|
179
Live Nation Entertainment
LYV
$41B
| $331K | 0.01% |
+5,000
| New | +$321K |
|
180
Intercontinental Exchange
ICE
$81B
| $330K | 0.01% |
+3,837
| New | +$313K |
|
181
IPG Photonics
IPGP
$4.09B
| $330K | 0.01% |
+2,141
| New | +$324K |
|
182
Tyler Technologies
TYL
$11.9B
| $329K | 0.01% |
+1,525
| New | +$331K |
|
183
Watsco Inc
WSO
$14.8B
| $326K | 0.01% |
+1,993
| New | +$313K |
|
184
Entegris
ENTG
$20.6B
| $325K | 0.01% |
+8,706
| New | +$330K |
|
185
Fastenal
FAST
$53B
| $319K | 0.01% |
+19,596
| New | +$323K |
|
186
Electronic Arts
EA
$52.4B
| $314K | 0.01% |
+3,100
| New | +$295K |
|
187
Microchip Technology
MCHP
$44.2B
| $314K | 0.01% |
+7,234
| New | +$321K |
|
188
Wabtec
WAB
$50.3B
| $314K | 0.01% |
+4,382
| New | +$311K |
|
189
Interactive Brokers
IBKR
$40.9B
| $312K | 0.01% |
+23,028
| New | +$312K |
|
190
Skyworks Solutions
SWKS
$9.1B
| $307K | 0.01% |
+3,978
| New | +$315K |
|
191
Booking.com
BKNG
$134B
| $304K | 0.01% |
+4,050
| New | +$291K |
|
192
Markel Group
MKL
$24.5B
| $304K | 0.01% |
+279
| New | +$292K |
|
193
Sensata Technologies
ST
$6.63B
| $302K | 0.01% |
+6,162
| New | +$293K |
|
194
Salesforce
CRM
$129B
| $297K | 0.01% |
+1,956
| New | +$307K |
|
195
US Bancorp
USB
$98.7B
| $297K | 0.01% |
+5,662
| New | +$292K |
|
196
M&T Bank
MTB
$35.6B
| $294K | 0.01% |
+1,731
| New | +$287K |
|
197
Avient
AVNT
$3.36B
| $284K | ﹤0.01% |
+9,035
| New | +$253K |
|
198
Autoliv
ALV
$8.44B
| $253K | ﹤0.01% |
+3,582
| New | +$262K |
|
199
Sociedad Química y Minera de Chile
SQM
$19.8B
| $217K | ﹤0.01% |
+6,990
| New | +$238K |
|
|
VNE
200
DELISTED
Veoneer, Inc.
VNE
| $167K | ﹤0.01% |
+9,658
| New | +$203K |
|
Similar funds
WSFS
AC
HIP
DT
ATPW
BT
NCM
MSU
Bellevue Group's Q2 2019 Portfolio in Review
As of Q2 2019, Bellevue Group held 220 positions worth $5.86B, up 222% from $1.82B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Bellevue Group deployed $4.05B of net new capital in Q2 2019, opening 83 new positions and adding to 86 existing holdings. Its largest new stake was Agios Pharmaceuticals: 3,128,134 shares worth $156M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 91% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $28.3M trimmed.
- Bellevue Group's largest Q2 2019 buy was Agios Pharmaceuticals: 3,128,134 shares worth $156M.
- Bellevue Group added most to Ionis Pharmaceuticals in Q2 2019, an estimated $541M increase.
- Bellevue Group's biggest Q2 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $28.3M.
- Bellevue Group fully exited Cencora in Q2 2019, selling an estimated $19.9M.
- Bellevue Group's ten largest holdings make up 42% of its $5.86B portfolio in Q2 2019.
- Bellevue Group opened 83 new positions and closed 19 in Q2 2019.
- Bellevue Group's portfolio value rose 222% quarter-over-quarter to $5.86B.
Based on Bellevue Group's 13F filing for Q2 2019, filed 14 Aug 2019.